Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis

Medicine and Dentistry

• Microglia 100%
• Central Nervous System 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Myeloid Cell 66%
• Receptor 66%
• Demyelination 66%
• Diseases 66%
• Serositis 33%
• Dendritic Cell 33%
• Triggering Receptor Expressed on Myeloid Cells 2 33%
• Neurodegeneration 33%
• Disease Exacerbation 33%
• Precursor 33%
• Protein Expression 33%
• Loss of Function Mutation 33%
• Monoclonal Antibody 33%
• Parenchyma 33%
• Inflammatory Infiltrate 33%
• Osteoclast 33%
• Autosomal Recessive Inheritance 33%
• Membrane Receptor 33%
• Myelin Oligodendrocyte Glycoprotein 33%

Immunology and Microbiology

• Microglia 100%
• Central Nervous System 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Myeloid 66%
• Dendritic Cell 33%
• Monoclonal Antibody 33%
• Protein Expression 33%
• Loss of Function Mutation 33%
• Inflammation Response 33%
• Spinal Cord 33%
• Precursor 33%
• Osteoclast 33%
• Parenchyma 33%
• Autosomal Recessive Inheritance 33%
• Myelin Oligodendrocyte Glycoprotein 33%
• Peptides 33%

Keyphrases

• Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Central Nervous System 30%
• DAP12 30%
• Experimental Autoimmune 30%
• Microglia 20%
• Nasu-Hakola Disease 20%
• Dendritic Cells 10%
• Neurodegeneration 10%
• Myeloid Cells 10%
• Autosomal Recessive 10%
• Demyelination 10%
• Protein Expression 10%
• Monoclonal Antibody 10%
• Gain-of-function mutation 10%
• Inflammatory Response 10%
• Membrane Receptors 10%
• Spinal Cord 10%
• Inflammatory Infiltrate 10%
• Osteoclast Precursors 10%
• Chronic Phase 10%
• 2 Receptor 10%
• Axonal Loss 10%
• TREM-1 10%
• Brain Parenchyma 10%
• Multinucleated Cells 10%
• Brain Pathology 10%
• Microglial Cells 10%
• Inflammatory Demyelination 10%
• Myelin Oligodendrocyte Glycoprotein 10%
• Disease Exacerbation 10%
• Effector Phase 10%
• Inflammatory Phase 10%